Monoclonal antibody D612
Alternative Names: D612Latest Information Update: 26 Aug 2002
At a glance
- Originator Nonindustrial source
- Class Antineoplastics; Monoclonal antibodies
- Mechanism of Action Immunomodulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Gastrointestinal cancer
Most Recent Events
- 02 Sep 1998 Profile reviewed
- 17 Jan 1996 Phase-II clinical trials for Gastrointestinal cancer in USA (IV)